Project description:In patients with primary breast cancer, neoadjuvant chemotherapy with doxorubicin plus pemetrexed followed by docetaxel (AP-D) is associated with a pathologic complete response (pCR) rate of 16.5%, and doxorubicin plus cyclophosphamide followed by docetaxel (AC-D) is associated with a pCR rate of 20.2%. Our primary objective was to identify single predictive genetic markers for achievement of pCR following either AP-D or AC-D treatment. Our main secondary objective was to detect treatment-group specific, pCR-predictive gene signatures.

2014-02-01 | E-TABM-1186 | biostudies-arrayexpress

Roerr et al CGH data

Project description:Comparative genomic hybridization experiments comparing DNA from experimentally evolved yeast strains to DNA from a euploid control.

2022-12-08 | GSE220549 | GEO

Reply by Xu et al. to Haouzi et al.

Project description: Not available

| S-EPMC7427385 | biostudies-literature

Reply by Pan et al. to Haouzi et al.

Project description: Not available

| S-EPMC7427396 | biostudies-literature

Hemani et al. reply.

Project description: Not available

| S-EPMC4404158 | biostudies-literature